CTCAE 5 Pro vs IOTOX Algorithm

CTCAE 5 Pro is designed to assist in the documentation, review, and reference of CTCAE-related information. This app is intended for informational support and is not designed for medical purposes such as diagnosis, clinical decision-making, or treatment recommendations. Users are responsible for verifying all information and making clinical decisions. ::::::::: Standard features (available to all users) :::::: - Streamlined CTCAE Document Access - Easily navigate CTCAE 5.0 documents using an intuitive interface. - Enhanced privacy with local data storage - protect your data by storing it locally instead of relying on cloud services, ensuring privacy and control. ::::::::: Premium Features (available with subscription) ::::::: - Version Comparison Tool - Easily compare different versions of CTCAE 5.0 and 4.03. - Advanced Notes feature - allows you to record CTCAEs in chronological order. You can also use hashtags and other features to efficiently organize and track notes for important information. - Custom App Creation Feature - Simply import a spreadsheet and convert it into a list app. No programming knowledge is required. - Flexible backup and archiving solution - easily back up and archive data in formats such as XLSX and CSV for versatility and accessibility. - More features are available in the Premium version. Note: With the Premium feature, a minimal number of files are automatically stored in a secure iCloud Drive to resume link information between files. This can be turned off based on user preference.

Immunotherapies have become essential in treating advanced malignancies. However, immunotherapies can attack healthy cells, leading to toxicities or side effects. To address how to best treat patients with these toxicities, the Internal Medicine division has collaborated with the Cancer Medicine division, as well as other divisions at MD Anderson, to create the Immuno-Oncology Toxicity (IOTOX) Leaders Group. ​​​​​​​ Clinical management algorithms depict best practices for evaluating, diagnosing, and treating specific conditions that arise during the course of cancer treatment. These algorithms are not intended to replace the independent medical judgment of the physician in the context of individual clinical circumstances to determine a patient's care.